Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Oncology
Published in: International Journal of Clinical Oncology 2/2005

01-04-2005 | ORIGINAL ARTICLE

Transperineal ultrasound-guided 12-core systematic biopsy of the prostate for patients with a prostate-specific antigen level of 2.5–20 ng/ml in Japan

Authors: Shinya Yamamoto, Ujin Kin, Kazuyoshi Nakamura, Masaaki Hamano, Yasuyo Nishikawa, Toshinao Takenouchi, Masayuki Maruoka

Published in: International Journal of Clinical Oncology | Issue 2/2005

Login to get access
Metadata
Title
Transperineal ultrasound-guided 12-core systematic biopsy of the prostate for patients with a prostate-specific antigen level of 2.5–20 ng/ml in Japan
Authors
Shinya Yamamoto
Ujin Kin
Kazuyoshi Nakamura
Masaaki Hamano
Yasuyo Nishikawa
Toshinao Takenouchi
Masayuki Maruoka
Publication date
01-04-2005
Publisher
Springer-Verlag
Published in
International Journal of Clinical Oncology / Issue 2/2005
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-004-0464-7

Other articles of this Issue 2/2005

International Journal of Clinical Oncology 2/2005 Go to the issue

ORIGINAL ARTICLE

Intracellular signaling in the induction of apoptosis in a human breast cancer cell line by water extract of Mekabu

REVIEW ARTICLE

Surgical treatment for metastatic malignancies. Anatomical resection of liver metastasis: indications and outcomes

INTRODUCTION TO REVIEW ARTICLES

How can blood metastasis be treated?

REVIEW ARTICLE

Surgical treatment for metastatic malignancies. Pulmonary metastasis: indications and outcomes

REVIEW ARTICLE

Mammary ductoscopy: past, present, and future

REVIEW ARTICLE

Surgical treatment for metastatic malignancies. Nonanatomical resection of liver metastasis: indications and outcomes
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits